Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Denis SoulieresSandrine Faivre

Abstract

Purpose: The preplanned exploratory analysis of the BERIL-1 trial presented here aimed to identify biomarkers of response to the combination of buparlisib and paclitaxel.Patients and Methods: BERIL-1 was a multicenter, randomized, double-blind, placebo-controlled phase II study. Patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) progressing on/after one previous platinum-based chemotherapy regimen in the recurrent or metastatic setting were treated with either buparlisib plus paclitaxel or placebo plus paclitaxel. Archival tumor tissue and ctDNA samples were analyzed for molecular alterations and immune infiltration using next-generation sequencing or immunohistochemistry.Results: Biomarker analyses were performed in randomized patients (n = 158) with available biomarker data. The most frequently (>5%) mutated genes were TP53, FAT1, TET2, KMT2D, PIK3CA, NOTCH1, NFE2L2, NOTCH2, CCND1, and CDKN2A Patients with SCCHN tumors (from various primary sites) having HPV-negative status (HR = 0.51), TP53 alterations (HR = 0.55) or low mutational load (HR = 0.57) derived overall survival (OS) benefit with the combination of buparlisib and paclitaxel. OS benefit with this combination was also increase...Continue Reading

References

Dec 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LavarinoF Zunino
Dec 26, 2001·Archives of Otolaryngology--head & Neck Surgery·J I LeeL Mao
Apr 18, 2002·Genes & Development·Bhuvanesh SinghArchontoula Stoffel
Sep 13, 2002·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Cristiane Helena SquarizeDécio Santos Pinto
Dec 21, 2007·The New England Journal of Medicine·M Luana PoetaWayne M Koch
Aug 2, 2008·Nature Medicine·Frank DiehlLuis A Diaz
Jan 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edmund A Mroz, James W Rocco
Jan 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federica PerroneLisa Licitra
Apr 27, 2010·Expert Opinion on Investigational Drugs·Andre Cassell, Jennifer R Grandis
Jun 18, 2010·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Christel Braemer Lajer, Christian von Buchwald
Dec 17, 2010·Nature Reviews. Cancer·C René LeemansRuud H Brakenhoff
Jul 27, 2012·The Journal of Clinical Investigation·S Michael Rothenberg, Leif W Ellisen
Apr 27, 2013·Cancer Discovery·Vivian W Y LuiJennifer R Grandis
Apr 27, 2013·Cancer Discovery·Curtis R PickeringMitchell J Frederick
May 7, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ArgirisR Mehra
Jun 25, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carole FakhryMaura Gillison
Jul 25, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tanguy Y SeiwertPeter S Hammerman
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Oct 11, 2014·World Journal of Clinical Oncology·Jeffrey M FriedmanAnthony J Cmelak
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Jan 30, 2015·Nature·UNKNOWN Cancer Genome Atlas Network
Apr 11, 2015·Cancer Cell·Suzanne L TopalianDrew M Pardoll
May 21, 2015·American Society of Clinical Oncology Educational Book·Pedro Henrique Isaacsson VelhoChristine H Chung
Jul 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yang LiWu Ren
Nov 29, 2015·Head & Neck·Rebecca FeldmanTheodoros Teknos
Feb 18, 2016·Head & Neck·Nghia NguyenUNKNOWN Head and Neck SPORE Program Investigators
Oct 11, 2016·The New England Journal of Medicine·Robert L FerrisMaura L Gillison
Oct 26, 2016·JCI Insight·Rajarsi MandalLuc Gt Morris
Dec 3, 2016·Nucleic Acids Research·Simon A ForbesPeter J Campbell
Dec 23, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jiqing SaiAnn Richmond
Apr 20, 2017·Genome Medicine·Zachary R ChalmersGarrett M Frampton

❮ Previous
Next ❯

Citations

Mar 21, 2019·Current Opinion in Oncology·Esma Saada-BouzidJoël Guigay
Aug 23, 2018·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Jelena MirkovicBrooke E Howitt
Aug 23, 2019·World Journal of Gastrointestinal Oncology·Si-Si LiRong Wan
Apr 28, 2020·JNCI Cancer Spectrum·Paul GougisChristophe Le Tourneau
Mar 1, 2019·Frontiers in Oncology·Esma Saada-Bouzid, Christophe Le Tourneau
Oct 31, 2020·Expert Opinion on Pharmacotherapy·Nicholas LenzeSiddharth Sheth
Mar 7, 2021·Critical Reviews in Oncology/hematology·Adriana Castelo de MouraEliete Neves Silva Guerra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cardiovascular Disease & TET2

Cardiovascular diseases are the number one cause of deaths globally. Tet methylcytosine dioxygenase 2 (TET2)-mediated hematopoiesis has been implicated in accelerating heart failure. Here is the latest research on cardiovascular diseases and TET2.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
J SignorovitchL Orsini
© 2022 Meta ULC. All rights reserved